MetLife (NYSE: MET) closes $10B U.S. variable annuity reinsurance deal

Rhea-AI Filing Summary

MetLife, Inc. filed a current report to disclose that, on December 1, 2025, it completed its previously announced transaction with Talcott Resolution Life Insurance Company to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves. This means a large block of MetLife’s variable annuity risk has been transferred to Talcott through a reinsurance arrangement.

The completion of this transaction is communicated under a Regulation FD disclosure, with further details provided in a related news release that is attached as an exhibit and incorporated by reference.

Insights

Insurance transactions analyst

MetLife has closed a sizable $10 billion variable annuity reinsurance deal.

MetLife reports completion of a transaction with Talcott Resolution Life Insurance Company to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves. Reinsurance moves insurance risk and related obligations to another carrier under agreed terms, which can reshape risk exposure and capital usage.

The item is presented as a Regulation FD disclosure, with the detailed terms contained in the referenced news release rather than here. Without those terms, the report mainly confirms that a previously announced deal has now closed, which is a notable risk-transfer step but not fully quantifiable from this excerpt alone.

The attached news release as of December 1, 2025 would give additional information on structure, capital effects, and any financial impact measures, which will frame how this large variable annuity reinsurance affects MetLife’s future financial profile.

0001099219false00010992192025-12-012025-12-010001099219us-gaap:CommonStockMember2025-12-012025-12-010001099219us-gaap:SeriesAPreferredStockMember2025-12-012025-12-010001099219us-gaap:SeriesEPreferredStockMember2025-12-012025-12-010001099219us-gaap:SeriesFPreferredStockMember2025-12-012025-12-01

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549  

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): December 1, 2025

METLIFE, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

1-15787

13-4075851

(Commission File Number)

(IRS Employer Identification No.)

200 Park Avenue,

New York,

NY

10166-0188

(Address of Principal Executive Offices)

(Zip Code)

(212) 578-9500

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report) 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01			MET			New York Stock Exchange
Floating Rate Non-Cumulative Preferred Stock, Series A, par value $0.01			MET PRA			New York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E			MET PRE			New York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F			MET PRF			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

Item 7.01 Regulation FD Disclosure.

On December 1, 2025, MetLife, Inc. issued a news release announcing it has completed its previously announced transaction with Talcott Resolution Life Insurance Company to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves. A copy of the news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The news release is furnished as of December 1, 2025, but not filed, pursuant to Instruction B.2 of Form 8-K.

Item 9.01 Financial Statements and Exhibits.

99.1 News release of MetLife, Inc. dated December 1, 2025, announcing it completed its transaction with Talcott Resolution Life Insurance Company to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves.

101 Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language)

104 Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

METLIFE, INC.

By:

/s/ Timothy J. Ring

Name:

Timothy J. Ring

Title:

Senior Vice President and Secretary

Date: December 1, 2025

3

FAQ

What transaction did MetLife (MET) announce in this 8-K?

MetLife announced that it has completed a transaction with Talcott Resolution Life Insurance Company to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves.

When did MetLife complete the $10 billion reinsurance transaction?

MetLife states that, on December 1, 2025, it completed its previously announced transaction with Talcott Resolution Life Insurance Company to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves.

What type of products are covered by MetLifes $10 billion reinsurance deal?

The reinsurance transaction covers approximately $10 billion of U.S. retail variable annuity and rider reserves, shifting these annuity-related obligations to Talcott Resolution Life Insurance Company under the agreement.

How is the MetLife (MET) reinsurance transaction disclosed to investors?

The transaction is disclosed under Item 7.01, Regulation FD Disclosure, and a news release dated December 1, 2025 describing the deal is attached as Exhibit 99.1 and incorporated by reference.

Does this 8-K describe financial details or impacts of MetLifes reinsurance transaction?

This report specifies that MetLife completed a transaction to reinsure approximately $10 billion of reserves and refers investors to the accompanying news release for further details, rather than providing additional financial metrics in the text itself.